D-0316-2021 Class I Terminated
FDA drug recall D-0316-2021 was initiated by Zydus Pharmaceuticals (USA) Inc on Feb 18, 2021 and is designated Class I. Reason for recall: Crystallization: customer complaints for crystallization in finished product. The recall status is terminated (terminated Nov 23, 2022). Affected quantity: 1,638 packs.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 7, 2021
- Initiation Date
- Feb 18, 2021
- Termination Date
- Nov 23, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 1,638 packs
Product description
Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured by: Cadila Healthcare Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534.
Reason for recall
Crystallization: customer complaints for crystallization in finished product.
Distribution pattern
USA Nationwide
Code information
Lot#: L000126, L000127, Exp 12/31/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0316-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026